Author:
Rao Yong,Li Jingying,Shi Lijuan,Chen Xiao,Hu Yun,Mao Yalin,Zhang Xiaoyan,Liu Xuqian
Abstract
AbstractTo analyze the mechanism of how interfering with the cytokeratin 19 (CK19) pathway via the ferroptosis pathway affects tumor biological behaviors in the process of oral squamous cell carcinoma (OSCC) development. TCGA was used to analyze the expression of CK19 in pan-cancer and head and neck squamous cell carcinoma (HNSC) and to explore the ferroptosis-related genes related to HNSC. The effect of silencing CK19 on the migration ability of HSC-4 cells was verified by wound healing and migration assay. HSC-4 cells with silencing of CK19 and tumor-bearing nude mouse model were constructed. RT-qPCR, immunofluorescence and western blot were used to analyze the expression of ferroptosis-related genes. CK19 is highly expressed in human OSCC and nude mice. The migration ability of cells in the CK19-silenced group was lower than that of the control group. In vivo and in vitro, CK19 was negatively correlated with the expression of ACSL4 and positively correlated with the expression of GPX4. Compared with the control group, GPX4 expression was down-regulated and ACSL4 expression was up-regulated in the CK19-silenced group. Silencing CK19 also increased intracellular Fe2+ content and MDA content. Silencing CK19 can affect the expression of GPX4 and ACSL4 to regulate ferroptosis and at the same time increase the content of MDA, Fe2+ and ROS levels, thereby activating the regulation of ferroptosis pathway in the development of OSCC.
Funder
The Key program of applied basic Research of Southwest Medical University
Science and Technology Program of Sichuan Province
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Liu, J. et al. circIGHG-induced epithelial-to-mesenchymal transition promotes oral squamous cell carcinoma progression via miR-142-5p/IGF2BP3 signaling. Cancer Res. 81, 344–355 (2021).
2. Lei, G., Zhuang, L. & Gan, B. Targeting ferroptosis as a vulnerability in cancer. Nat. Rev. Cancer 22, 381–396 (2022).
3. Kuburich, N. A., den Hollander, P., Pietz, J. T. & Mani, S. A. Vimentin and cytokeratin: Good alone, bad together. Semin. Cancer Biol. https://doi.org/10.1016/j.semcancer.2021.12.006 (2022).
4. Vaidya, M., Dmello, C. & Mogre, S. Utility of keratins as biomarkers for human oral precancer and cancer. Life (Basel) 12, 343 (2022).
5. Lu, Q. et al. CK19 promotes ovarian cancer development by impacting on Wnt/β-catenin pathway. OncoTargets Ther. https://doi.org/10.2147/OTT.S242778 (2020).